Safer nicotine wiki

Nicotine / THR - Statements from Experts

Revision as of 11:50, 25 January 2023 by Skip (talk | contribs) (→‎Robin Koval)

Scientists, Professors, Medical Professionals, Tobacco Control and Public Health Leaders, along with Lawmakers are speaking out in support of adult use of Tobacco Harm Reduction (THR) products to help people quit smoking and to prevent relapse.

A picture of scientific notes, chemical formula with the words "THR Statements from Experts. Statements: Medical Professionals, Scientists, Tobacco Control etc"
Statements From Experts




Argentina

Dr. Diego Verrastro


 
Argentina Dr. Diego Verrastro


Milton Klun

Pharmacist Universidad Nacional del Sur. Argentina



Australia

Ron Borland PhD

Quote Source / Bio and Photo

 
Ron Borland PhD


Wayne Hall

Quote Source / Bio and Photo

 
Wayne Hall PhD


Dr. Alex Wodak AM


 
Dr Alex Wodak AM


Colin Mendelsohn, MB BS


 
Dr Colin Mendelsohn


Judith Watt

Former Executive Director, NCD Alliance Former Director, Quit Victoria,


Senator Hollie Hughes


Fiona Patten MP



Austria

Bernhard-Michael Mayer, PhD

Professor of Pharmacology and Toxicology Institute of Pharmaceutical Sciences Karl-Franzens-Universität Graz Austria


Ernest Groman, MD


 
Ernest Groman MD


Belgium

Frank Baeyens, PhD


 
Frank Baeyens


Karolien Adriaens, PhD


 
Karolien Adriaens


Canada

Michael Chaiton



Patrick Fafard, PhD

Full Professor Centre for Health Law, Policy, and Ethics Graduate School of Public and International Affairs University of Ottawa



Kellie Ann Forbes BScN

Here

Amelia Howard, Sociologist



Ian Irvine, PhD


 
Ian Irvine PhD


Martin Juneau MPs, MD, FRCP(C)


 


Chris Lalonde, PhD



Clifford Garfield Mahood, O.C.

Founding Executive Director (1976-2012) Non-Smokers’ Rights Association Toronto Canada



Dr John Oyston


 


David Sweanor, JD

Quote Source / Bio and Photo

 
David Sweanor JD


Neda Debassige Toeg, BSP, RPh


 
Neda Debassige Toeg BSP RPh, President Aboriginal Pharmacists Association of Canada


Mark Tyndall MD ScD FRCPC


 
Mark Tyndall, Founder of My Safe Society


Chili

Hernán Prat, MD, PhD

Professor at the University of Chile. Former Director of the Cardiovascular Department of the Clinical Hospital of the University of Chile. Former president of the Chilean Society of Hypertension. Chile



Colombia

Hugo Caballero Durán, MD

Former president of the Colombian Society of Pneumology. Former Clinical Scientific Director of Marly Clinic. Director of the Pneumology and Respiratory Therapy Service, Marly Clinic Bogotá, Colombia



Czech Republic

Eva Králíková, MD

Professor Institute of Hygiene and Epidemiology Centre for Tobacco-Dependence First Faculty of Medicine and General Hospital Charles University Prague Czech Republic


Pavel Bém MD

Member of the Global Commission on Drug Policy Head of the Clinical Department, Adictology Clinic, Charles University Former Mayor of Prague Member of The National Drug Commission Office of the Government of the Czech Republic


Democratic Republic of the Congo

Samuel Mukandi, BA



Ecuador

Enrique Teran, MD, PhD

Professor College of Health Sciences - Universidad San Francisco de Quito. Ecuadorian Academy of Medicine Academy of Science of Ecuador Ecuador


Francisco E. Urrestra. MD.

Medical Director Hospital Clinica Metropolitana. Ibarra.


César Paz y Miño, MD, PhD

Director, Centro de Investigacion Genética y Genómica and Specialist in Genetics and Human Molecular Biology Universidad UTE Quito, Ecuador



England/(UK)

Sanjay Agrawal, MD, MBChB


 
Sanjay Agrawal MD, Professor of Respiratory medicine University Leicester, Chair of Royal Collage Physicians Tobacco Advisory Group


Adam Afriyie, BSc


 
Adam Afriyie, BSc, Chair of Parliamentary Office Science and Technology


Deborah Arnott


 
Deborah Arnott, MBA, CEO ASH-UK


Prof Paul Aveyard


John Britton, MD

Quote Source / Bio and Photo

 
John Britton, MD, Director UK Center For Tobacco and Alcohol Studies, Professor of Epidemiology University Nottingham


Dr Leonie Brose


Sharon Cox, PhD


 


Lynne Dawkins, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • Disclosures: I have provided consultancy for the pharmaceutical industry relating to the development of smoking cessation products. I have no conflicts with respect to the tobacco or e-cigarette industry.


 


Dr Matthew Evison


 


Patricia Kovacevic, JD


 


Floe Foxon, BSc


 


Martin Dockrell


Stuart Griffiths

  • Quote Source
  • Director of research, services and policy at Yorkshire Cancer Research
  • “When it comes to helping people quit for good, being able to offer vaping products is essential. They are an incredibly effective aid in helping people give up cigarettes.”


Peter Hajek, PhD


 


Sarah Jackson, PhD, MSc


 


David Halpern

  • We should deliberately seek to make e-cigs widely available, and to use regulation not to ban them but to improve their quality and reliability.
  • Quote Source


Benjamin Human

Source of name

Martin Jarvis ODE, PhD

Quote Source / Bio and Photo

 


Sir Norman Lamb

Graphics Source / Follow on Twitter

 


Rosemary Leonard, MBE, MA, MB, BChir, MRCGP, DRCOG

Quote Source / Bio / Follow on Twitter

 


Jim McManus, OCDS, FFPH

Jim McManus, Director of Public Health, Hertfordshire: How and why I changed my mind on e-cigarettes,

Ann McNeill, PhD

 


Olivia M Maynard, PhD

Senior Lecturer, School of Psychological Science Bristol Population Health Science Institute MRC Integrative Epidemiology Unit Bristol, United Kingdom


Marcus Munafò, PhD

Professor of Biological Psychology and MRC Investigator MRC Integrative Epidemiology Unit School of Psychological Science University of Bristol United Kingdom


Clive Bates

Quote Source / Bio and Photo / Follow on Twitter

 


John Newton, FRCP FFPH FRSPH

Quote Source / Bio

 


Caitlin Notley, PhD


 


David Nutt DM, FRCP, FRCPsych, FSB, FMedSci

Quote Source / Bio and Photo / Follow on Twitter

 


Dr. Sudhanshu Patwardhan

Snus Forum Interview

Debbie Robson, PhD

 


Louise Ross


 


Dr Kathryn Scott

  • Quote Source
  • chief executive at Yorkshire Cancer Research
  • "Easy and reliable access to vaping products will give more people in Yorkshire the best chance of quitting for good.”


Lion Shahab, PhD CPsychol AFBPsS

  • Quote Source / Bio / Photo / Follow on Twitter
  • Disclosures: LS has received a research grant, honoraria for talks, consultancy and travel expenses to attend meetings and workshops from pharmaceutical companies that make smoking cessation products (Pfizer; Johnson & Johnson). He has never received any funding or other monetary benefits from the tobacco or e-cigarette industry.


 


Erikas Simonavičius, PhD

 


Frances Thirlway, PhD, MSc


 


Suzi Gage



Emma V Beard



Dr Russell Thorpe

Quote source

Robert West, PhD

Professor Emeritus in Health Psychology, University College London


Dr Kevin Murphy


France

Jacques Le Houezec, PhD


 


Professor Bertrand Dautzenberg


 


Philippe Arvers, MD, PhD

Tobaccologist ans addictologist Université Grenoble Alpes France


Marion Adler, PhD

Smoking Cessation Specialist Hôpital Antoine Béclère Clamart France


Germany

Peter Liese MEP

Tweet about Peter

Frank Sitta

tweet about Frank

PROFESSOR HEINO STÖVER


 


Prof. Dirk Ziebolz


Dr Ingo Schröder


Greece

Konstantinos Farsalinos, MD, MPH

Quote Source / Bio and Photo / Follow on Twitter

 


Iceland

G. Karl Snæbjörnsson, MD


 


India

Dr Nimesh Desai


 


Dr Kiran Melkote, MBBS, MS


 


Aparajeet Kar, MD

Consultant Pulmonology and Critical Care Sir H.N Reliance Foundation Hospital Mumbai India


Rohan Sequeira, MD, PhD

Professor of Internal Medicine Specialist in Non-Invasive Cardiology, Diabetes, Endocrinology and Obesity Management Jaslok Hospital and Research Centre Mumbai India


Ireland

Dr Garrett McGovern


 


Italy

Riccardo Polosa


 


Umberto Tirelli MD

Professor Director, Cancer Center Clinica Mede Sacile


Pietro Fiocchi

Follow on Twitter / Tweet with info / Quote:

 


Japan

Naohito Yamaguchi, MD

Chief of Research Division, Saiseikai Research Institute of Health Care and Welfare Former Professor of Public Health, School of Medicine, Tokyo Women's Medical University


Kenya

Joseph Magero, BBA


 


Lithuania

Morgana Danielė

video on twitter

Malaysia

Dr Steven Chow

Quote Source / Bio and Photo

 


Dr Arifin Fii


Shamsul Bahri Mohd Tamrin, PhD

Professor of Occupational Safety and Health/Ergonomics Department of Environmental and Occupational Health University Putra Malaysia Shamsul Bahri Mohd Tamrin, PhD


Mexico

Roberto A Sussman, PhD


 


Christian Heinrich Henonin MD

MIPH International Public Health. Medical professor, researcher and health consultant Mexico


Morocco

Imane Kendili MD


 


New Zealand

Ruth Bonita, MPH, PhD, MD (hon) and Robert Beaglehole, MD, DSc


 


Marewa Glover, PhD


 


Deborah Hart LLB


 


Natalie Walker, PhD

Associate Professor of Population Health and Director of the Centre for Addiction Research, National Institute for Health Innovation, Faculty of Medical and Health Sciences, University of Auckland


Eliana Golberstein Rubashkyn, BSc Pharm, B. Chem


 


George Laking, MD, PhD

Chair, End Smoking New Zealand


Yolande Jeffares


Dr Murray Laugesen

  • Follow on Twitter
  • “…inhaling mist from the e-cigarette is rated several orders of magnitude (100 to 1000 times) less dangerous than smoking tobacco cigarettes.”
  • Quote Source


PM Jacinda Ardern


Nigeria

Aishat Alaran

  • Follow on Twitter #WomenInTHR

MPhil Candidate at University of Cambridge. Commonwealth Shared Cambridge Trust Scholar. Public Health Researcher

Norway

Karl E Lund, PhD


 


Pakistan

Dr Ashar Ahmed

Source for name and quote

Philippines

Dr. Fernando Fernandez

Quote Source / Bio / Photo

 


Ron Christian G. Sison, MLS(ASCPi), MPH

Assistant Professor Lead Convenor Harm Reduction Alliance of the Philippines Manila Philippines


Arleen R. Reyes, DMD, ICD, ICCDE

Past President, Philippine Dental Association Chairman, Commission on Dental Education Asia -Pacific Dental Federation Philippines


Dr. Rafael R. Castillo


 


Poland

Andrzej Sobczak, PhD

Professor Head of Department of General and Inorganic Chemistry Faculty of Pharmaceutical Sciences in Sosnowiec Medical University of Silesia Katowice Poland


Romania

Mihaela Răescu Phd


 


Scotland

Dr. Ehsan Latif


Prof Linda Bauld, OBE


 


South Africa

Dr Kgosi Letlape


 


Solomon Rataemane


 


South Korea

Young-bum Park, PhD

Professor Department of Economics Hansung University South Korea


Spain

Fernando Fernández Bueno, MD

Oncological surgeon at the Hospital Central de la Defensa Gómez Ulla Professor at the University of Alcalá de Henares Madrid Spain


Josep María Ramón Torrell, MD, PhD.

Professor of Epidemiology and Public Health University of Barcelona Head of Clinical Prevention Research Group Bellvitge Biomedical Research Institut Head of Tobacco Prevention Service Bellvitge Hospital Barcelona, Spain


José David García Muñiz, MD, PhD

Clinical Pharmacology and Internal Medicine Clinical Trials Coordinator, Principal Investigator University Hospital of Ceuta Spain


Francisco Garcia Sierra, MD.

Head of the Nephrology Service University Hospital of Ceuta Spain


Angel González Ureña, PhD

Emeritus Professor of Physical Chemistry. Complutense University of Madrid


Maria del Mar Sangüesa Jareño, MD

Intensive Care Specialist University Hospital of Ceuta, Spain


Antonio Sierra, MD, PhD

Professor of Preventive Medicine and Public Health at the University of La Laguna. Former Dean of the Faculty of Medicine of the University of La Laguna Former General Director of Public Health of the Government of the Canary Islands


Carmen Escrig, PhD


 


Manuel Linares Abad, PhD


Miguel de la Guardia PhD

Professor of Analytical Chemistry University of Valencia Spain


José Mª García Basterrechea, MD

Associate Professor of Medicine University of Murcia Former head, Addiction and Dual Pathology Unit Reina Sofía Hospital. Spain.


Singapore

Andrew John da Roza

Psychotherapist - Addictions Promises Health Care Pte. Ltd. Singapore


Tan Kok Kuan, MD

Medical Director Dr Tan Medical Center Novena Medical Center Singapore


Sweden

Anders Milton MD, PhD

Quote Source / Bio and Photo

 


Lars Ramström PhD

Quote Source / Bio and Photo

 


KARL FAGERSTRÖM PhD


 


Switzerland

Tikki Elka Pang, PhD

Former Director, Research Policy & Cooperation, WHO, Geneva Switzerland


Jean-François Etter, PhD

Professor of public health Institute of Global Health, Faculty of Medicine University of Geneva


Moira Gilchrist PhD


 


Tunisia

Fares Mili MD-CTTS- NCTTP

Quote Source: / Bio and Photo

 


United Arab Emirates

Cother Hajat, MBBS PhD FFPH FRCP



United States

David Abrams PhD

  • Photo: Documentary - You Don't Know Nicotine / Quote / Bio
  • E-cigarettes are substantially less harmful than burning toxic tobacco. They can help some people who have been unable to quit to switch and save their lives. The science in the last 2-3 years has become incredibly strong. It was the science that drove me to change my mind. I think we've forgotten it's the smoker and potential smoker we're supposed to be helping. They're people too. You can't forget that.


 


Jasjit S Ahluwalia, MD, MPH, MS


 


Alex Azar, JD


 


Jeffrey Brandes


 


Kenneth Michael Cummings PhD, MPH


 


David Dobbins, JD, MPH

Source of Quote / Source of Photo

 


Clifford E. Douglas, J.D


 


Allan Erickson


 


Jonathan Foulds PhD


 


Abigail S. Friedman PhD


 


Stephen F. Gambescia, PhD


 


Karen K Gerlach, PhD, MPH


 


Bill Godshall

Quote Source / Photo Source

 


Dr. Scott Gottlieb


 


Scott Hadland, MD, MPH, MS, BS


 


Nan Hayworth, MD


 


Matthew Holman, PhD


 


Matthew Wayne Johnson, Ph.D.

Quote / Bio and Photo

 


Peter Killeen PhD


 


Bethea A Kleykamp, MA, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • COI: I currently have no conflicts of interest with respect to tobacco, vaping or pharmaceutical industries. From May 2014 to September 2018, I provided harm reduction consulting services to an e-cigarette company (NJOY) and a tobacco company (RJ Reynolds) through my work at Pinney Associates.


 


Robin Koval


 


Ted Kyle, RPh, MBA


 


Jody Lanard MD


 


Cam Nereim, MD, FAAP

Photo and Bio / Follow on Twitter / Quote Source

 


Joel Nitzkin, MD


 


Michael Ogden, Phd


 


Cheryl K. Olson, Sc.D.


 


Jason Osborne


 


Laura Leigh Oyler


 


Amanda Palmer, PhD


 


Michael F. Pesko, PhD


 


Carl V. Phillips, MPP, PhD


 


Helen Redmond, LCSW


 


Vaughan Rees, PhD


 


Veronique de Rugy, PhD


 


Steven A Schroeder, MD


 


Sheila Vakharia, PhD MSW


 


Kenneth Warner, PhD


 


Mitch Zeller, JD

Bio / Photo Source / Quote Source

 


Dr. Jerome Adams


File:USA - Jerome Adams.jpg


Tom Miller JD


 



Scott Ballin, JD

  • Photo: Monique Calello / The News Leader
  • Bio: Has served as chairman of the Coalition on Smoking or Health (the precursor to the Campaign for Tobacco-Free Kids); vice president of the American Heart Association; steering committee of the Alliance for Health Economic and Agriculture Development (AHEAD); advisor to the Food and Drug Law Institute’s tobacco conferences; advisor to the University of Virginia's Morven Dialogues on tobacco, nicotine and harm reduction.
  • Statement: Most smokers want to quit and if we can provide those smokers with science based, consumer acceptable lower risk products we could fundamentally alter the current marketplace and save hundreds of thousands of premature deaths.
  • Source: Comments on vaping and tobacco harm reduction from expert stakeholders
    • This year approximately 8 million people will die prematurely from smoking. I am deeply disappointed with what can only be described as an ongoing 'dark ages' approach to tobacco control. While many traditional forms of tobacco control remain useful and effective, little has been done by the WHO and many other mainstream public health organizations to acknowledge and think about how regulation, research, technology and innovation can be collectively harnessed to give the billion addicted cigarette smokers viable science based lower risk products. Science and 'safe-haven' engagement and debate continues to be displaced with polarized thinking that often is more focused on getting media attention than actually finding workable win-win solutions for the good of society.
    • Scott D. Ballin, JD
    • Health Policy Consultant
    • Former Vice President and Legislative Counsel, American Heart Association
    • Former Chairman of the Coalition on Smoking OR Health (AHA, ASCS. ALA)
    • Advisor to the University of Virginia, Institute for and Engagement and Negotiation (The Morven Dialogues)


Ovide Pomerleau, PHD



Richard H Carmona MD, MPH, FACS



Tamar Antin, DrPH, MAA



Dorothy K. Hatsukami, PhD


Kenneth A. Perkins, PhD


Harry A. Lando, PhD


Nancy A. Rigotti, MD


David J. K. Balfour, DSc


Dr. Michael Madden

Dr. Michael Madden: Clearing the air about youth vaping

Scott Leischow, PhD


Caryn Lerman, PhD


Gary E. Swan, PhD


Alex Liber


Dr. Cheryl Healton

Founding President and CEO of American Legacy Foundation (created from MSA Funds, now known as the Truth Initiative); Dean of School of Global Public Health and Professor of Public Health Policy and Management, NYU School of Global Public Health; Founding chair of the Public Health Practice Council of the Association of Schools of Public Health; Serves on the National Board of Public Health Examiners, the Betty Ford Institute, Lung Cancer Alliance, Board of Directors at the Association of Schools and Programs of Public Health, and the Board of Directors at HealthRight International. Tobacco Harm Reduction Quote: E-cigarette Summit 2021 We treat addiction to combustible tobacco differently than addiction to other products with respect to harm reduction approaches. We are spending way too much time on infighting and too little time on finding common ground to massively reduce combustible tobacco use and ending the false equivalency between products. Smoking remains a worldwide tragedy causing a billion lives at stake in this century alone. Lower risk products exist to help those unable or unwilling to quit. We have abandoned our harm reduction approach in public health when it comes to saving smokers. Retirement from American Legacy (now Truth)


Lynn Kozlowski


Ethan A Nadelmann

  • Follow on Twitter
  • Source: Comments on vaping and tobacco harm reduction from expert stakeholders
    • It took WHO all too many years to embrace “harm reduction” thinking and policies vis a vis consumers of illicit drugs but it eventually did. Hundreds of thousands, possibly millions of lives, could have been saved if WHO had acted earlier to transcend the political forces and counterproductive ideologies and rhetoric that drove the war on drugs and its insistence on punitive abstinence-only policies.
    • Yet now we see WHO repeating very similar mistakes as it resists and dismisses the technological innovations in tobacco and nicotine products that could radically reduce associated harms to both consumers and society at large. The organization’s leaders need to open their eyes and summon the courage to follow the science, not the politics. Failure to do so may ultimately result in the emergence of an international tobacco/nicotine prohibition regime with all the failures, costs and counter-productive consequences of the failed global drug prohibition regime.
    • Ethan A Nadelmann - Bio and Photo
    • Founder & Former Executive Director (2000-2017)
    • Drug Policy Alliance
    • New York and International


Raymond S. Niaura, PhD


John Seffrin, MD, PhD

Photo Source #1 and Source #2 Bio: Former CEO of the American Cancer Society and ACS Cancer Action Network. Served on the White House Advisory Group on Prevention, Health Promotion, and Integrative and Public Health, as well as the Advisory Committee to the Director of the Centers for Disease Control and Prevention. He also served on the National Cancer Policy Board of the Institute of Medicine and the National Cancer Legislation Advisory Committee. He is a past president of the International Union Against Cancer. He helped to create the National Center for Tobacco-Free Kids (now the Campaign for Tobacco-Free Kids) Source #1 and Source #2 Statement: Technologies/alternatives exist today that can help people quit smoking or at least reduce significantly their consumption of burned tobacco, which is what kills them. After fighting the tobacco epidemic for over 5 decades, we now have proven harm reduction methods to help us avoid a carnage in otherwise preventable deaths.

Michael Siegel

Visiting Professor, Department of Public Health and Community Medicine Tufts University School of Medicine Boston


Paul Newhouse

Quote source "It [nicotine] seems very safe even in nonsmokers. In our studies we find it actually reduces blood pressure chronically. And there were no addiction or withdrawal problems, and nobody started smoking cigarettes. The risk of addiction to nicotine alone is virtually nil."

Robin Mermelstein, Ph.D.

Distinguished Professor, Liberal Arts and Sciences Psychology Department Director, Institute for Health Research and Policy Co-Director, Center for Clinical and Translational Science University of Illinois at Chicago


Charles A. Gardner, PhD


Arielle Selya, PhD

(need to find a quote)

(Add disclosure about now working @Pinney)

Thomas J. Glynn, PhD

Adjunct Lecturer Prevention Research Center School of Medicine, Stanford University Formerly, Associate Director, Cancer Control Science Program, U.S. National Cancer Institute, and Director, Cancer Science and Trends, American Cancer Society


Daniel Wikler, Ph.D.


Michael Fiore

"In just today, we are going to lose 20 of our residents. Twenty individuals in Wisconsin are going to die prematurely of a disease directly caused by their smoking, on average, robbing them of 10 to 15 years of life." " Many adults don't want children exposed to secondhand smoke. Vaping is, without a question, less dangerous than cigarette smoking."

Thomas Brandon, PhD, United States

 
Moffitt Cancer Center



Earlier this year, the findings from a major clinical trial, published in the New England Journal of Medicine, showed that e-cigarettes were almost twice as effective as the nicotine patch for producing one year of smoking cessation. These findings added to those of other, smaller studies previously published.

“This could be a game-changer for lots of people,” says Thomas Brandon, Ph.D., director of Moffitt’s Tobacco Research and Intervention Program and chair of the Department of Health Outcomes and Behavior. “It means that for smokers who have not been able to quit by using the available medications, vaping might be worth a try. But it is important to completely switch from smoking to vaping to get the most health benefits.”

Thomas Brandon, PhD, is the Director of the Tobacco Research and Intervention Program and Chair of the Department of Health Outcomes and Behavior at Moffitt Cancer Center. He is also Professor of Psychology and Oncologic Sciences at the University of South Florida

SEE: Tweet w/graphic


Neal Benowitz


Sally Satel


Dr. Brad Rodu


Carrie Wade, PhD



Robert Sklaroff


Suzanne M. Colby, PhD


Arielle Selya



Chelsea Boyd



Venezuela

Natasha A. de Herrera, PhD

Clinical Psychology Centro Medico Docente la Trinidad Psychiatric Unit Smoking Cessation Clinic Caracas Venezuela


Statements by Multiple Parties

2021: One hundred specialists call for WHO to change its hostile stance on tobacco harm reduction - new letter to FCTC delegates published


2021: Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder


2021: 75 Tobacco Control experts ask CDC to change the name of EVALI


2019: Testimony for New York Senate hearing on vaping safety - Clive Bates and David Sweanor


2018: Letter from seventy-two specialists in nicotine science, policy and practice


Suggestions to add to this page

See Letter: The benefits of vaping

CAPHRA Expert Advisory Group

Two from Canada

ADEBISI Yusuff Adebayo

  • (CASA Board - Africa) Nigeria/UK

Dr. Kgosi Letlape - Physician and health care leader from South Africa.

Delon Human

Professor Tony Axéll

Associate Professor Coral Gartner

Professor Dr Michael Kunze

2023 Dr Ekaterina Netchitailova

2022 LESS HARM: INTERNATIONAL DECLARATION FOR A SMOKE-FREE SPAIN

  • Signed by 170 experts

Doctors, scientists ask Marcos to sign vape bill

French Prime Minister

Maybe organization, too? SMOKING CESSATION: VAPE OR NOT VAPE?

2019 E-cigarettes need to be regulated, not banned: Dr Patrick Basham Read more at: https://health.economictimes.indiatimes.com/news/policy/e-cigarettes-need-to-be-regulated-not-banned-dr-patrick-basham/72392936

expert reaction to Department of Health press release ‘e-cigarettes could be prescribed on the NHS in world first’

E-cig Summit UK 2021 speakers

A New International Commission of Experts Finds the Global Fight Against Smoking Has Stalled

CRUCIAL STEP IN TOBACCO HARM REDUCTION

Canada

Sec. Azar (need to find original source, might be a youtube video) VTA Graphic and Hawaii Graphic

expert reaction to WHO report on nicotine and tobacco products

Michael Erikson

Ending Cigarette Use By Adults In A Generation Is Possible

Letter with names to research

More names to research for positive statements

Jaron Hoani King

Pritika Kumar R-Street

Comments on vaping and tobacco harm reduction from expert stakeholders

More names on this doc

World No Tobacco Day: Here's why WHO’s approach to tobacco cessation needs an overhaul

The Truth Initiative, too, once embraced harm reduction. Its former board chairman, Tom Miller, Iowa’s long-serving attorney general, still argues that e-cigarettes are a “means to saving millions of lives.” Cheryl Healton, its former CEO, and David Abrams, formerly executive director of the Schroeder National Institute of Tobacco Research and Policy Studies, which is housed at the Truth Initiative, are harm-reduction advocates. So is Steven Schroeder, for whom the institute is named. Found here

72 Statements to WHO

M.O.V.E.

Dr. Derek Yach

  • “We’ve been very clear that we support provisions that children should never vape or smoke. However, our main objective is to help adult smokers quit by making cessation aids accessible and to support adult smokers switching to approved harm reduction products. These include snus, e-cigarettes, heated-tobacco products and nicotine pouches,” says Yach. “In the long term, tackling cessation together with harm reduction is the only way to bring smoking rates down relatively soon. If today’s adult smokers quit or switch, even into their fifties or sixties, they will see improvements in their quality of life.”

Quotes

Attaullah Ahmadi

  • notes from an email
  • Attaullah Ahmadi is a Medical Doctor from Afghanistan. He is currently pursuing his MPH with a focus on Epidemiology and Biostatistics at the École des Hautes Études en Santé Publique (EHESP) in France Attaullah Ahmadi is the senior advisor to Global Health Focus (GHF), a network of academics and researchers who seek to achieve health for all. He is also a member at Youth Editorial Board of Public Health Challenges (a Wiley journal). He has served as the GHF Director of Research for Asia and also as a Research Associate at the Medical Research Center of Kateb University. Attaullah Ahmadi seeks to address health inequities and has published many scientific papers on various health topics in developing countries including Afghanistan, analyzing their health systems and highlighting the challenges they face.
Retrieved from ‘https://safernicotine.wiki/mediawiki/index.php?title=Nicotine_/_THR_-_Statements_from_Experts&oldid=27320’